American Thoracic Society International Conference

Infants with obstructive sleep apnea may also be at an increased risk of negative outcomes associated with COVID-19.

There are a number of reasons why identifying obstructive sleep apnea in infants is difficult, but new research shows feeding dysfunction could be an early link.

Little is understood about the systemic markers of worsening COPD. Investigators have observed at least 3 novel pathways.

A new assessment shows risk reduction is even more significant among COPD patients who have smoked.

Patients with OSA during REM sleep experience lower oxygen saturation and longer times with oxygen saturation.

Individuals with obstructive sleep apnea were more frequently male, obese, and had more coronary heart disease when compared to those without OSA.

A six-month study shows the common OSA therapy could have long-term benefit for reducing eventual cardiovascular risk.

Treatment drug results in a significant reduction in severe exacerbations for patients with eosinophil ≥150 cells/µL.

An assessment of FF/UMEC/VI in a single inhaler show its benefit in respiratory function among COPD patients at 24 weeks.

A 52-week assessment shows patients of varying interleukin serum levels equally benefitted from the TSLP inhibitor.

New ATS findings show the IL-5 inhibitor has sustained and oftentimes improved benefit in patients from 6 months to 12.

Dr. Ian Pavord discusses new meta-analyses of dupilumab planned for ATS 2020 on the DocTalk podcast.

When compared to placebo, benralizumab results in a significantly improved asthma exacerbation rates.

New research show younger age is associated with a non-response to biologic agents.

While initial double therapy has proven effective in treating pulmonary arterial hypertension, adding selexipag to the treatment regimen of macitentan and tadalafil could be beneficial in this patient population.

Patients with the splice variant were significantly less likely to have raised blood eosinophil counts.

Electronic nicotine device use could lead to a number of respiratory outcomes such as wheezing and dry coughs.

A new study shows consistent confidence and anxiety of self-care with the injectable biologic in patients with asthma.

In a pair of Canadian cohorts, investigators discover asthmatic children are older on the epigenetic clock.

Greater BMI scores are linked to longer ventilator needs and higher risk of acute respiratory distress syndrome.

In a study of 578 infants, investigators discover more female infants suffered from OSA.

An assessment of a combined pharmacologic and cognitive behavioral therapy program shows patients improve FEV1, FVC, and other metrics.

Between 2006-2016, the hospital mortality rates for patients with ILD did not change.

New cohort data comparing the lone regulated IPF therapies show one is associated with reduced mortality—while the other has a better continuation of care.

Overall rates of pulmonary rehabilitation rose in areas with greater program density, but rates for African Americans remained low despite greater program density.

The rare disease patient population is smaller and in need of immediate treatment. What's next after the SENSCIS trial results?

The signs and symptoms of the rare, chronic condition are not consistently detected in the first line of care.

A new study from ATS showed an early symptom of Alzheimer disease is more prevalent in older patients with moderate OSA.

Sepsis patients with an acuity score of 3 received antibiotics half an hour later than patients with the slightly more critical score of 2.

Neighborhoods redlined in the 1930s continue to feel the effects of the racially discriminatory practice, including differences in asthma-related emergency visits.